Eliquis (apixaban) is a commonly prescribed medication for patients with atrial fibrillation (AFib). It’s an anti-coagulant that helps prevent blood clots from forming in the heart, which can lead to stroke. But it’s important to understand how to use Eliquis correctly to get the most benefit. In this blog post, we’ll discuss why Eliquis is prescribed and what medical professionals need to know to recommend and monitor its use safely and effectively.
Eliquis is a prescription medication used to help prevent strokes and blood clots in people with atrial fibrillation (Afib), a type of irregular heartbeat. It is also used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). Eliquis belongs to a class of drugs called factor Xa inhibitors. Eliquis works by blocking the activity of factor Xa, a protein needed for blood clotting. This action helps to reduce the risk of stroke and other serious complications in people with Afib. Eliquis is taken as a pill, either once or twice daily. The exact dosage depends on the individual's medical condition and response to treatment. People taking Eliquis should be monitored closely and may need regular blood tests to check for side effects. Common side effects of Eliquis include bleeding, bruising, and mild dizziness.
Eliquis to help reduce your risk of blood clots and stroke. Here's what you need to know about how to use Eliquis correctly. Eliquis is a blood thinner, also known as an anticoagulant. It works by preventing blood clots from forming or getting larger. That's important because blood clots can cause strokes, heart attacks, and other serious problems. Eliquis comes in pill form and is taken either once or twice daily. You should take it at the same time each day to help you remember. You can take Eliquis with or without food. If miss a dose of Eliquis, take it as soon as you remember unless it is close to the time for next dose. In that case, skip the missed dose and take your next dose at the regular time. Do not take two doses of Eliquis at the same time to make up for a missed dose.
Eliquis is a novel anticoagulant medication that has been proven effective in reducing the risk of stroke in patients with atrial fibrillation. However, like all medications, Eliquis has its own set of pros and cons that medical professionals should be aware of. PROS: Eliquis is highly effective in reducing the risk of stroke in patients with atrial fibrillation. Eliquis has a very low risk of bleeding compared to other anticoagulant medications. Eliquis does not require frequent blood monitoring like other anticoagulants. The once-daily dosing schedule of Eliquis is convenient for patients. CONS: Eliquis is a relatively new medication, so its long-term safety profile is not yet known. Eliquis is more expensive than other anticoagulants on the market. Some patients may experience side effects such as headache, diarrhea, or fatigue with Eliquis use.
Eliquis to help reduce your risk of stroke. Here's what you can expect when taking this medication. Eliquis is a blood thinner that works by preventing blood clots from forming. It's important to take Eliquis exactly as prescribed to minimize the risk of bleeding. You should take Eliquis twice daily, with or without food. If miss a dose, take it as soon as remember unless it is close to the time for your next dose. In that case, skip the missed dose and resume usual dosing schedule. Common side effects of Eliquis include bruising and bleeding more easily than usual.
If you are a medical professional who is looking for alternatives to Eliquis, there are a few options that you can consider. Pradaxa and Xarelto are two other anticoagulants that can be used to treat afib. Both of these medications work in a similar way to Eliquis, but they have different side effects and risks.
We hope this article has provided medical professionals with a better understanding of how to use Eliquis for the best results in treating atrial fibrillation. By following the correct dosage and administration instructions and staying aware of possible side effects, patients can experience successful treatment while minimizing risk.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation